Seeking Alpha


Send Message
View as an RSS Feed
View popster76's Comments BY TICKER:
Latest  |  Highest rated
  • Zacks' Bull Of The Day: ConocoPhillips [View article]
    Very nice summary of why COP is a buy for the energy play in your portfolio and why I'm happy it's in my Roth! Thank you.
    Jul 8 06:17 PM | 1 Like Like |Link to Comment
  • Pfizer: Pfine With Or Without AstraZeneca [View article]
    To bberuch: I was at Wyeth when we were acquired by Pfizer and R&D facilities were Not discarded as you "recall"? Wyeth purchased the 1 million sq. ft. facility in Collegeville, PA because we had outgrown the campus in Radnor, PA, and Pfizer is located there today! You should also recall that many blockbuster products of Wyeth came to PFE including Prevnar and vaccine expertise, Enbrel and a state-of-the-art biotech facility in Ireland and expertise in immuno-oncology. The Wyeth acquisition has exceeded payback for Pfizer $68 billion price tag without question.
    Jul 6 11:04 AM | 1 Like Like |Link to Comment
  • The Gift That Keeps Giving [View article]
    Thanks for another interesting and enjoyable article George, and your daily tales of option calls & puts and covered contracts makes me content to just stick with my portfolio of dividend aristocrats. I wish you Good investing luck for your efforts and enjoy hearing about your strategy and research on a wide variety of stocks, some of which I even own!
    Jul 5 12:12 PM | 2 Likes Like |Link to Comment
  • 3 Reasons Why McDonald's Is A McSell [View article]
    The reason I can afford Starbucks is the dividends MCD is paying me tax-free from my Roth, but then very few millenials would care because they have their heads buried in their social media devices. Useless article once again from SA editors!
    Jul 4 03:37 PM | 5 Likes Like |Link to Comment
  • Briefly On Pfizer: It's Time To Buy [View article]
    Well, I am long PFE and very happy about it! It's a solid dividend paying stock with good management and R&D upside potential so will continue to hold.
    Jul 3 09:46 PM | 2 Likes Like |Link to Comment
  • Why Apple Acquiring Tesla Makes Sense [View article]
    At 1 cent per click this article is overpriced!!!
    Jul 3 10:02 AM | 11 Likes Like |Link to Comment
  • Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions [View article]
    Gilead has sales of $2.1 billion, compared to $50 billion Pfizer, so acquisition at $5-6Billion would be very easy!
    Jul 3 09:32 AM | 1 Like Like |Link to Comment
  • Altria's Strong Dividend And Beer Investment Portend A Bright Future [View article]
    Solid summary of MO's ability to continue its dividend payout for next few years and allow us to see how the e-cig sector works out for Altria. Hold on MO.
    Jul 2 10:07 AM | Likes Like |Link to Comment
  • Best S&P 500 Stocks According To Shareholder Yield: Pfizer [View article]
    Excellent analysis Arie with a lot of good info and agree with many commenters that plan to Hold their PFE positions as do I. Disagree with some that were unhappy about AZN acquisition, because this mega-merger was not the best strategy. Pfizer should continue to find smaller biotech partners to acquire or collaborate with, such as Cellectis and Glycomimetics, in order to bring new breakthrough drugs to market.
    Jul 1 02:39 PM | Likes Like |Link to Comment
  • Pfizer: Pfine With Or Without AstraZeneca [View article]
    Hey Sun, thanks for the article links on Xeljanz in treating alopecia which could prove to be a nice piece of serendipity for those suffering from loss of hair. I worked on tofacitinib at Pfizer before I retired in 2011 and can assure you it is in clinical development trials for additional indications, but not for alopecia. I am sure researchers from the company will end up collaborating with this physician to explore this potential new use for Xeljanz, as we can recall the use of Propecia for growing hair when it was originally developed for hypertension. My recommendation on PFE is Hold or Buy.
    Jun 29 02:53 PM | 1 Like Like |Link to Comment
  • Pfizer: Pfine With Or Without AstraZeneca [View article]
    Very few companies are without some history of greedy incompetent management and in fact very few government agencies & departments! At least with a corporation you can vote your shares or sell them. With govt. you are stuck with greedy incompetence until the next election, so that's life in the big city Pete & Melman, so good luck and happy investing.
    Jun 29 02:39 PM | 1 Like Like |Link to Comment
  • Pfizer: Pfine With Or Without AstraZeneca [View article]
    You should learn more about the new R&D facility PFE is building in Cambridge, MA which will include collaborations with MIT, Harvard and other universities in the search for new knowledge in science and medicine. Perhaps this will make up for closing down Kalamazoo in the '70s? I was not part of R&D management at PFE, it was Global Strategic Marketing.
    Jun 29 02:33 PM | Likes Like |Link to Comment
  • What If Legacy Pharmaceutical And Consumer Business Keeps Falling For Merck? [View article]
    The PD-1 class of monoclonal antibody drugs are one of the hottest new cancer fighting tools discovered in the last twenty years and will definitely rejuvenate MRK's fortunes. The acquisition of Idenix was another smart move and the current management is beginning to hit their stride after some early missteps that encourage this long MRK investor.
    Jun 27 08:16 PM | 3 Likes Like |Link to Comment
  • Pfizer: Pfine With Or Without AstraZeneca [View article]
    Melman, like Pete you are living in the past and need to get a grip on what's happening now...of course companies buy other companies and then cut costs, overhead and employees to make the synergies work! This is as old and commonplace as M&A for ever. You refuse to invest in companies with incompetent R&D management...good luck with that will you determine when and where to invest?
    Jun 27 12:37 AM | 1 Like Like |Link to Comment
  • Pfizer: Pfine With Or Without AstraZeneca [View article]
    Earth to Pete, it's not 2006 any more, it's 2014. You need to move on and get a grip on reality. If you look at nearly every Fortune500 company's Executive management, you will find gross overpayment and if this was a criteria for investing in stocks, you should buy bonds & T-bills.
    Jun 27 12:30 AM | 1 Like Like |Link to Comment